Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...
A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback